Bank of New York Mellon Corp lowered its holdings in National Health Investors Inc (NYSE:NHI) by 0.6% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 306,067 shares of the real estate investment trust’s stock after selling 1,973 shares during the period. Bank of New York Mellon Corp owned approximately 0.73% of National Health Investors worth $22,552,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also bought and sold shares of NHI. Forsta AP Fonden bought a new stake in National Health Investors during the 2nd quarter worth approximately $464,000. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp grew its holdings in National Health Investors by 69.6% during the 2nd quarter. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp now owns 22,900 shares of the real estate investment trust’s stock worth $1,687,000 after acquiring an additional 9,400 shares during the last quarter. Tower Research Capital LLC TRC bought a new stake in National Health Investors during the 2nd quarter worth approximately $678,000. Paloma Partners Management Co bought a new stake in National Health Investors during the 2nd quarter worth approximately $566,000. Finally, Macquarie Group Ltd. grew its holdings in National Health Investors by 15.5% during the 2nd quarter. Macquarie Group Ltd. now owns 13,400 shares of the real estate investment trust’s stock worth $987,000 after acquiring an additional 1,800 shares during the last quarter. 70.11% of the stock is owned by hedge funds and other institutional investors.
NYSE:NHI opened at $77.06 on Friday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 14.53 and a current ratio of 14.53. National Health Investors Inc has a 52 week low of $62.71 and a 52 week high of $81.60. The firm has a market capitalization of $3.21 billion, a PE ratio of 14.46, a PEG ratio of 3.58 and a beta of 0.30.
National Health Investors (NYSE:NHI) last posted its quarterly earnings data on Tuesday, November 6th. The real estate investment trust reported $0.97 EPS for the quarter, missing the Zacks’ consensus estimate of $1.39 by ($0.42). National Health Investors had a net margin of 53.15% and a return on equity of 11.56%. The firm had revenue of $74.92 million during the quarter, compared to the consensus estimate of $73.72 million. During the same period in the prior year, the company posted $1.37 earnings per share. The company’s revenue for the quarter was up 5.0% compared to the same quarter last year. Equities research analysts forecast that National Health Investors Inc will post 5.51 earnings per share for the current year.
In other news, Director Robert A. Mccabe, Jr. sold 1,250 shares of the company’s stock in a transaction on Monday, November 26th. The shares were sold at an average price of $75.41, for a total value of $94,262.50. Following the sale, the director now directly owns 13,120 shares of the company’s stock, valued at approximately $989,379.20. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 5.19% of the company’s stock.
A number of research firms have weighed in on NHI. Wells Fargo & Co reissued a “hold” rating on shares of National Health Investors in a report on Tuesday, August 28th. Zacks Investment Research lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, August 14th. Cantor Fitzgerald boosted their target price on shares of National Health Investors from $75.00 to $80.00 and gave the stock a “neutral” rating in a report on Wednesday, August 8th. SunTrust Banks reissued a “hold” rating and set a $79.00 target price on shares of National Health Investors in a report on Wednesday, August 8th. They noted that the move was a valuation call. Finally, Stifel Nicolaus set a $83.00 target price on shares of National Health Investors and gave the stock a “buy” rating in a report on Tuesday, August 7th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the stock. National Health Investors currently has a consensus rating of “Hold” and an average price target of $75.22.
ILLEGAL ACTIVITY WARNING: This piece was originally posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another site, it was stolen and republished in violation of international trademark and copyright law. The original version of this piece can be viewed at https://www.americanbankingnews.com/2018/11/30/bank-of-new-york-mellon-corp-sells-1973-shares-of-national-health-investors-inc-nhi.html.
National Health Investors Profile
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Featured Article: Inflation
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.